Glioblastoma is a highly malignant primary brain tumor with limited treatment options and poor prognosis. Despite current treatment approaches, including surgical resection, radiation therapy, and chemotherapy with temozolomide, glioblastoma remains mostly incurable due to its invasive growth pattern, limited drug penetration beyond the blood-brain barrier, and resistance to conventional therapies. One of the main challenges in glioblastoma treatment is effectively eliminating infiltrating cancer cells that remain in the brain parenchyma after primary tumor resection.
Chiariello, M., Inzalaco, G., Barone, V., Gherardini, L. (2023). Overcoming challenges in glioblastoma treatment: targeting infiltrating cancer cells and harnessing the tumor microenvironment. FRONTIERS IN CELLULAR NEUROSCIENCE, 17 [10.3389/fncel.2023.1327621].
Overcoming challenges in glioblastoma treatment: targeting infiltrating cancer cells and harnessing the tumor microenvironment
Inzalaco Giovanni;Barone Virginia;
2023-01-01
Abstract
Glioblastoma is a highly malignant primary brain tumor with limited treatment options and poor prognosis. Despite current treatment approaches, including surgical resection, radiation therapy, and chemotherapy with temozolomide, glioblastoma remains mostly incurable due to its invasive growth pattern, limited drug penetration beyond the blood-brain barrier, and resistance to conventional therapies. One of the main challenges in glioblastoma treatment is effectively eliminating infiltrating cancer cells that remain in the brain parenchyma after primary tumor resection.File | Dimensione | Formato | |
---|---|---|---|
chiariello et al 2023.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
3.82 MB
Formato
Adobe PDF
|
3.82 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1252814